C9041 – Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9041
- Long description
- Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
- Short description
- Inj, coagulation factor xa
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J7169
- Added
- April 1, 2019
- Last change
- July 1, 2020 – No change
- Termination date
- June 30, 2020
Frequently asked questions
What is HCPCS code C9041?
C9041 is a HCPCS Level II code for injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg. It was discontinued on June 30, 2020.
Does Medicare cover C9041?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9033 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- C9034 – Injection, dexamethasone 9%, intraocular, 1 mcg
- C9035 – Injection, aripiprazole lauroxil (aristada initio), 1 mg
- C9036 – Injection, patisiran, 0.1 mg
- C9037 – Injection, risperidone (perseris), 0.5 mg
- C9038 – Injection, mogamulizumab-kpkc, 1 mg
- C9039 – Injection, plazomicin, 5 mg
- C9040 – Injection, fremanezumab-vfrm, 1mg
- C9042 – Injection, bendamustine hcl (belrapzo), 1 mg
- C9043 – Injection, levoleucovorin, 1 mg
- C9044 – Injection, cemiplimab-rwlc, 1 mg
- C9045 – Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- C9046 – Cocaine hydrochloride nasal solution (goprelto), 1 mg
- C9047 – Injection, caplacizumab-yhdp, 1 mg
- C9048 – Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
- C9049 – Injection, tagraxofusp-erzs, 10 mcg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.